Minkowski O. : Historical development of the theory of pancreatic diabetes. Introduction and translation by R. Levine. Diabetes , 38:1-6, 1989
2.
Banting FG, Best CH, Collip JB, et al: Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J12:141-146, 1922
3.
Bliss M.: The Discovery of Insulin. Chicago, IL, University of Chicago Press, 1982
4.
Kahn CR, Shechter Y.: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas , in Gilman AF, Rall TW, Nies AS, (et al) (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed. New York, NY, Pergamon Press, 1990 , p 1464
5.
Orci L.: The insulin cell; its cellular environment and how it processes (pro)insulin . Diabetes Metab Rev2:71-106,1986
6.
Polonsky KS, Rubenstein AH: Current approaches to measurement of insulin secretion. Diabetes Metab Rev2:315-329,1986
7.
Meglasson MD , Matschinsky FM: Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev2:163-214, 1986
8.
Porte D. Jr, Halter JB: The endocrine pancreas and diabetes mellitus, in Williams RH (ed): Textbook of Endocrinology , 6th ed. Philadelphia, PA, Saunders Co, 1981, pp 716-843
9.
Shimazu T., Ishikawa K.: Modulation by the hypothalamus of glucagon and insulin secretion in rabbits; studies with electrical and chemical stimulations. Endocrinology108:605-611, 1981
10.
Meglasson MD , Matschinsky FM: Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev2:163-214, 1986
Sodoyez JC, Sodoyez-Goffaux F., Guillaume M., et al: 123I-insulin metabolism in normal rats and humans: External detection by a scintillation camera. Science2:865-868, 1983
Rabkin R., Ryan MP, Duckworth WC: The renal metabolism of insulin. Diabetologia27:351-357, 1984
15.
Kahn CR, Shechter Y.: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas , in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, eighth ed. New York, NY, Pergamon Press, 1990, p 1468
16.
Kahn CR, White MF: The insulin receptor and the molecular mechanism of insulin action . J Clin Invest82:1151-1156, 1988
17.
Kasuga M., Karlsson FA, Kahn CR: Insulin stimulates the phosphorylation of the 95,000 dalton sub-unit of its own receptor. Science215:185-187, 1982
18.
Rosen OM: After insulin binds. Science237:1452-1458, 1987
19.
Kahn CR, White MF: The insulin receptor and the molecular mechanism of insulin action . J Clin Invest82:1151-1156,1988
Ellis L., Clauser E., Morgan DO, et al: Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin stimulated kinase activity and uptake of 2-deoxy glucose . Cell45:721-732, 1986
22.
Chou CK, Dull TJ, Russell DS, et al: Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem262:1842-1847, 1987
23.
Suzuki K., Kono T.: Evidence that insulin causes translocation of glucose transport activity of the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA77:2542-2545, 1980
24.
Simpson IA, Cushman SW: Hormonal regulation of mammalian glucose transport. Ann Rev Biochem55:1059-1089,1986
25.
James DE, Brown R., Navarro J., et al: Insulin regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature333:183-185, 1988
26.
Garvey WT, Hucksteadt TP, Birnbaum MJ: Pretranslational suppression of an insulin responsive glucose transporter in rats with diabetes mellitus. Science245:60-63, 1989
Kahn CR, Shechter Y.: Insulin, oral hypoblycemic agents, and the pharmacology of the endocrine pancreas , in Gilman AF, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed. New York, NY, Pergamon Press, 1990, pp 1473-1474
29.
Galloway JA : Insulin treatment for the early 80's: Facts and questions about old and new insulins and their usage. Diabetes Care3:615-622, 1980
30.
Deckert T.: Intermediate-acting insulin preparations: NPH and lente. Diabetes Care3:623-626, 1980
31.
Francisco GE : Diabetes mellitus, in DiPiro JT, Talbert R, Hayes P, Yee G, et al (eds): Pharmacotherapy, A Pathophysiologic Approach. New York, NY, Elsevier , 1989
32.
Home PD, AlbertiKGMM: The new insulins: Their characteristics and clinical indications. Drugs24:401-413, 1982
33.
Deckert T.: Intermediate-acting insulin preparations: NPH and lente. Diabetes Care3:623-626,1980
34.
Skyler JS: Insulin pharmacology. Med Clin North Am72:1337-1354, 1988
35.
Kahn CR, Shechter Y.: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas , in Gilman AF, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed. New York, NY, Pergamon Press, 1990, p 1475
36.
Frazier LM, Mulrow CD, Alexander LT, et al: Need for insulin therapy in type II diabetes mellitus: A randomized trial. Arch Intern Med147:1085-1089, 1987
37.
Skyler JS: Insulin pharmacology. Med Clin North Am72:1337-1354, 1988
38.
Kahn CR, Shechter Y.: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas , in Gilman AF, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed. New York, NY, Pergamon Press, 1990, p 1477
39.
Position Statement : Insulin Administration. Diabetes Care14:30-33, 1991 (suppl 2)
40.
Galloway JA , Spradlin CT, Nelson RL, et al: Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care4:366-376, 1981
41.
American Diabetes Association: The Physician's Guide to Type II Diabetes (NIDDM): Diagnosis and Treatment . New York, NY, American Diabetes Association, 1984, pp 1-112
42.
Gregerman RI: Diabetes mellitus, in Barker LR, Burton JR, Zieve PD (eds): Principles of Ambulatory Medicine. Baltimore, MD, Williams and Wilkins, 1986, pp 951-986
43.
Cahill GF, McDevitt HO: Insulin-dependent diabetes mellitus: The initial lesion. N Engl J Med304:1454-1465, 1981
44.
American Diabetes Association: The Physician's Guide to Type II Diabetes (NIDDM): Diagnosis and Treatment . New York, NY, American Diabetes Association, 1984, pp 1-112
45.
Wilson RM, Clarke P., Barkes H., et al: Starting insulin treatment as an outpatient: Report of 100 consecutive patients followed up for at least one year. JAMA256:877-880, 1986
46.
Gregerman RI : Diabetes mellitus, in Barker LR, Burton JR, Zieve PD (eds): Principles of Ambulatory Medicine . Baltimore, MD, Williams and Wilkins , 1986, pp 951-986
47.
Cryer PE, Gerich JE: Glucose counterregulation, hypoglycemia and intensive insulin therapy in diabetes mellitus. N Engl J Med313:232-241, 1985
48.
Heine RJ, et al: Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins. Diabetologia27:558-562, 1984
49.
Olsson P-O. , Hans A., Henning VS: Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin. Diabetes Care10:473-477,1987
50.
Best JD, Ley CJ, Strauss Bjg, et al: Clinical effects of mixing short- and intermediate-acting insulins in treatment of non-insulin-dependent diabetes. Med J Aust146:621-627, 1987
51.
Drug Evaluations Annual1992, American Medical Association, Chicago, IL
52.
Adams PS, Haines-Nutt RF, Town.R: Stability of insulin mixtures in disposable plastic insulin syringes. J Pharm Pharmacol39:158-163, 1987
53.
Peters AL, Davidson MB: Effect of storage on action of NPH and regular insulin mixtures. Diabetes Care10:799-800,1987
54.
Jawadi MH, Ho LS: Stability and reproducibility of biologic activity of premixed and short-acting and intermediate-acting insulins. Am J Med81:467-471, 1986
55.
Ahrens ER, Gossain VV, Rovner DR: Human insulin: Its development and clinical use. Postgrad Med80:181-187, 1986
56.
Antidiabetic agents, in American Hospital Formulary Service Drug Information 86, Bethesda , American Society of Hospital Pharmacists, 1984, pp 1562-1594
57.
Galloway JA : Insulin treatment for the early 80's: Facts and questions about old and new insulins and their usage. Diabetes Care3:615-622, 1980
58.
Skyler JS: Plethora of insulins, editorial. Diabetes Care3:638-639, 1980
59.
Sonnenberg GE, Berger M.: Human insulin: Much ado about one amino acid? EditorialDiabetologia25:457-459, 1983
60.
Hepburn DA, Frier BM: Hypoglycemic unawareness and human insulin. Lancet June 17, 1989 (letter) 1393
61.
Mulhauser I. , Heinemann L., Fritsche E., et al: Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations . Diabetes Care14:745-749, 1991
62.
Clarke WL, Gonder-Frederick LA, Richards FE, et al: Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Diabetes40:680-685, 1991
63.
Kern W., Lieb K., Kerner W., et al: Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes39:1091-1095, 1990 64. Jellin JM (ed): Pharm Letter6:34, 1990
64.
Jellin JM (ed): Pharm Letter5:41, 1989
65.
Jellin JM: Pharm Letter7:60, 1991
66.
Point StudyGroup: One-year trial of a remote-controlled implantable insulin infusion system in type I diabetic patients. Lancet2:866-869, 1988
67.
Halle J-P., Lambert J., Lindmeyer I., et al: Twice-daily mixed regular and NPH insulin injections with new jet injector versus conventional syringes: Pharmacokinetics of insulin absorption . Diabetes Care9:279-282, 1986
68.
Malone JI, Lewitt S., Grove WP, et al: Comparison of insulin levels after injection by jet stream and disposable insulin syringe. Diabetes Care9:637-640, 1986
69.
Edsberg B., et al: Sprinkler needle spreads insulin load for diabetic patients . Br Med J294:1373-1376, 1987
70.
American Diabetes Association Task force : Position statement on jet injectors. Diabetes Care11:600-601, 1988
71.
Salzman R., Manson JE, Griffing GT, et al: Intranasal aerosolized insulin: Mixed-meal studies and long-term use in type I diabetes. N Engl J Med312:1078-1084, 1985
Alejandro R. , Noel J., Latif Z., et al: Human islet cell transplantation: University of MiamiSchool of Medicine experience, in Brunetti P, Waldhausl WK (eds): Advanced Models for the Therapy of Insulin-Dependent Diabetes. New York, NY, Raven Press , 1987
74.
Pfeiffer EF : On the way to the automated (blood) glucose regulation in diabetes: The dark past, the grey present, the rosy future. Diabetologia30:51-65, 1987
75.
Francisco GE : Diabetes mellitus, in DiPiro JT, Talbert R, Hayes P, Yee G, et al (eds): Pharmacotherapy, A Pathophysiologic Approach. New York, NY, Elsevier , 1989 p 815
76.
Gossel TA, Wuest JR: Advising patients on insulin use. Mississippi Pharmacist September/October 1991, pp 35-37
77.
Position Statement: Insulin Administration, Diabets Care, 14:30-33, 1991 (suppl 2)
78.
Francisco GE : Diabetes mellitus, in DiPiro JT, Talbert R, Hayes P, Yee G et al (eds): Pharmacotherapy, A Pathophysiologic Approach. Elsevier, New York, NY1989, p 812